MeSH D009748 - nutrition disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009750:Nutritional and metabolic diseases
D006986:Hypervitaminosis a
0 Companies
0 Drugs
Success rate
D007228:Infant nutrition disorders
0 Companies
0 Drugs
Success rate
D015362:Child nutrition disorders
0 Companies
0 Drugs
Success rate
D019282:Wasting syndrome
0 Companies
0 Drugs
Success rate
D044342:Malnutrition
0 Companies
0 Drugs
Success rate
D044343:Overnutrition
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Fresenius Kabi | Medium chain triglycerides | Smoflipid | 2016-07-13 |
Clinical Trials
Historical Success Rate
Phase 1
50%2/4
Phase 2
20%2/10
Phase 3
0%0/4
Approved: 0Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use